Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in vitro.
Kato
Tomoyuki
T
Department of Urology, Yamagata University School of Medicine, Yamagata, Japan.
Bilim
Vladimir
V
Yuuki
Kaori
K
Naito
Sei
S
Yamanobe
Takuya
T
Nagaoka
Akira
A
Yano
Ikuya
I
Akaza
Hideyuki
H
Tomita
Yoshihiko
Y
D001500:BCG Vaccine / Q000494:pharmacology*; D048708:Cell Growth Processes / Q000276:immunology; D045744:Cell Line, Tumor; D017358:Cell Wall Skeleton / Q000276:immunology / Q000494:pharmacology; D051417:Focal Adhesion Kinase 1 / Q000096:biosynthesis / Q000276:immunology; D016193:G1 Phase / Q000276:immunology; D006801:Humans; D039081:Integrin alpha5beta1 / Q000096:biosynthesis / Q000276:immunology; D009163:Mycobacterium bovis / Q000276:immunology*; D015398:Signal Transduction; D051195:Toll-Like Receptor 2 / Q000096:biosynthesis / Q000276:immunology; D051197:Toll-Like Receptor 4 / Q000096:biosynthesis / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*
D001500:BCG Vaccine; D017358:Cell Wall Skeleton; D039081:Integrin alpha5beta1; C495342:TLR2 protein, human; C495345:TLR4 protein, human; D051195:Toll-Like Receptor 2; D051197:Toll-Like Receptor 4; D051417:Focal Adhesion Kinase 1; C496050:PTK2 protein, human